REMEMULGENE ARELACTIBAC
UNII R2BZ24VRD8

Substance Identification & Data

This profile provides standardized clinical and technical data for Rememulgene Arelactibac, uniquely identified by the FDA Unique Ingredient Identifier (UNII) R2BZ24VRD8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
R2BZ24VRD8
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
REMEMULGENE ARELACTIBAC
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C211717
National Cancer Institute reference terminology for clinical and research data.
INN ID
13290
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rememulgene Arelactibac. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

REMEMULGENE ARELACTIBAC

Common Names & Synonyms

NON-PATHOGENIC, FOOD-GRADE LACTIC ACID BACTERIUM LACTOCOCCUS CREMORIS (L. CREMORIS) STRAIN AUC1000, ALR DELETION DERIVATIVE OF L. CREMORIS MG1363, TRANSFORMED WITH A PLASMID ENCODING THE TRANSGENES FOR (I) HUMAN COLONY STIMULATING FACTOR 1 (CSF-1 ISOFORM 3), (II) HUMAN FIBROBLAST GROWTH FACTOR 2 (FGF-2 ISOFORM 3), AND (III) HUMAN INTERLEUKIN 4 (IL-4 ISOFORM-1) WHOSE EXPRESSION IS CONTROLLED BY A GAD OPERON CASSETTE COMPRISING THE GADR REGULATOR GENE AND A GADCB REGULATORY REGION. EACH OF THE THREE TRANSGENES IS OPTIMISED FOR EXPRESSION IN L. CREMORIS AND IS COUPLED TO THE L. CREMORIS USP45 SIGNAL SEQUENCE PRECEDED BY A RIBOSOME BINDING SITE DERIVED FROM THE GADC (CSF-1), ATPG (FGF-2) AND LACA (IL-4) GENES OF L. CREMORIS, RESPECTIVELY. THE PLASMID ALSO CONTAINS AN ALANINE RACEMASE (ALR) GENE FOR PLASMID SELECTION
REMEMULGENE ARELACTIBAC [INN]

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus